Quarterly report [Sections 13 or 15(d)]

SEGMENT INFORMATION (Details)

v3.25.3
SEGMENT INFORMATION (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
SEGMENT INFORMATION        
Revenues, net $ 635,224 $ 0 $ 948,362 $ 7,665
Cost of implants and other costs 358,812 0 358,813 1,667
Research and development 1,004,660 460,138 1,463,439 1,210,334
Selling, general and administrative 1,145,353 1,192,869 3,254,760 2,773,288
Depreciation and amortization 71,986 6,714 168,807 20,141
Total operating expenses $ 2,580,811 $ 1,659,721 $ 5,245,819 $ 4,005,430